CTOs on the Move

Lyndra

www.lyndra.com

 
Lyndra Therapeutics is pioneering the first-ever oral, ultra-long-acting, sustained release therapies, which have the potential to fundamentally change the way people take medicine by enabling patients to take a pill once a week rather than daily. The Company`s breakthrough Extended-Release Oral Capsule is designed to provide consistent drug levels for an entire week or as long as a month, from one, normal-sized capsule – something no oral therapy has ever achieved before. Lyndra`s robust pipeline is made up of therapies with established and well-known safety profiles across a number of disease areas in which non-adherence is known to be a ...
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.lyndra.com
  • 65 Grove Street Suite 301
    Watertown, MA USA 02472
  • Phone: 857.201.5314

Executives

Name Title Contact Details
Jacqueline Fernandes
 Vice President of Data Compliance and Information Technology Profile
Kyle Haraldsen
 Chief Technology Officer Profile
Orn Almarsson
 Chief Technology Officer Profile

Funding

Lyndra raised $23M on 04/13/2017
Lyndra raised $55M on 01/29/2019
Lyndra raised $13M on 07/30/2019

Similar Companies

Cell Signaling Technology

Cell Signaling Technology, Inc. is a Danvers, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Karuna Therapeutics

At Karuna, our purpose is to create and deliver transformative medicines for people living with psychiatric and neurological conditions. Through the cultivation of our deep expertise in neuroscience, and inventive thinking around drug discovery and development, we are advancing a pipeline of novel medicines with the goal of providing a meaningful difference in the lives of those affected by these conditions. Our culture is defined by our passion to serve those affected by mental illness. We are purpose-driven and intentional. We know impactful innovations don`t come easy, but are borne from passion and hard work. Together, we are working toward a goal bigger than ourselves.

Coley Pharmaceutical Group

Coley Pharmaceutical Group is a Wellesley Hills, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cortexyme

Cortexyme is developing therapeutics based on data supporting a new theory of the cause of Alzheimer`s and other neurodegenerative disorders. Cortexyme is targeting a specific, undisclosed pathogen tied to neurodegeneration. The target has been validated in a number of animal models and Cortexyme is currently testing several potential lead therapeutics in preclinical studies.

Epredia

Improving lives by enhancing precision cancer diagnostics.